| Typicality: | 0.445 |
| Saliency: | 0.502 |
| currently | 8 | temporal |
| for different types of cancers | 8 | other |
| for eye conditions | 6 | other |
| compound → be in → clinical trials | 18 |
| compound → be tested in → clinical trials | 13 |
| compound → be used in → clinical trials | 3 |
| compound → be tested in → human clinical trials | 3 |
| negative | neutral | positive |
| 0.056 | 0.704 | 0.240 |
| Raw frequency | 37 |
| Normalized frequency | 0.502 |
| Modifier score | 0.440 |
| Perplexity | 124.610 |